Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Triple Negative Breast Neoplasms × Imatinib Mesylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Breast Neoplasms 1

Interventions

camrelizumab 2 Injections 2 toripalimab 1 epigallocatechin gallate 1 atezolizumab 1 Zinc 1 Tablets 1 Quercetin 1 Nivolumab 1 Metformin 1 Imatinib Mesylate 1 Gemcitabine 1 Everolimus 1 Epirubicin 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05722795 2025-07-09

I-CONIC

Vastra Gotaland Region

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡